MARLBOROUGH, Mass. and MOUNTAIN VIEW, Calif., April 1, 2015 -- (Healthcare Sales & Marketing Network) -- Boston Scientific Corporation (BSX) announces that it has signed a definitive agreement to acquire Xlumena, Inc., a venture-backed medical device company that develops, manufactures and sells minimally invasive devices for Endoscopic Ultrasound (EUS) guided transluminal drainage of targeted areas within the gastrointestinal tract. The deal is expected to close this week.
BOSTON, April 15, 2015 -- (Healthcare Sales & Marketing Network) -- InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in stent embolic protection systems ("EPS"), today announced the completion of its sales restructuring program which began on January 4, 2015. The restructuring was implemented to conserve capital and to align the organization to a new commercial strategy built on third party distribution partners. Reflecting some impact from the transition, as well as the trend towards drug eluting stent use in STEMI patients discussed during our fourth quarter 2014 earnings call last month, total revenues for the first quarter 2015 were approximately $500,000, down sequentially from $850,000 in the fourth quarter 2014.
AngioDynamics has announced a worldwide licensing agreement with privately-held EmboMedics of Minneapolis, USA, which develops injectable and resorbable microspheres. Embolization is the fastest growing segment in interventional radiology, and this newly formed strategic relationship will allow AngioDynamics to leverage the talent and knowledge of its sales team to re-enter the approximately US$150 million addressable global embolic market.
Medtronic has launched the Fortrex over-the-wire (OTW) percutaneous transluminal angioplasty (PTA) balloon catheter. Fortrex utilises a high pressure balloon to break up the blockages and open the vessels to help maintain arteriovenous access in the peripheral vascular system.
BTG has announced the treatment of the first patient in Singapore with TheraSphere, a treatment for primary liver cancer and metastatic colorectal cancer, specifically engineered to deliver powerful doses of radiation to the tumour while minimising exposure to normal tissue in a procedure called radioembolization.
A study presented at the Society of Interventional Radiology’s (SIR’s) 2015 annual scientific meeting reveals that a new angiographic imaging platform (AlluraClarity, Philips Healthcare) maintains similar procedure time as a current C-arm imaging platform (Allura, Philips), yet with substantially reduced radiation exposure for uterine artery embolization procedures.
Researchers from Stanford University have created a mobile application to allow rapid identification of all inferior vena cava filter types and related complications. This scrollable app can be used to optimise care of patients with inferior vena cava filters, especially those with indwelling filters, they say. The app can run on Apple (iOS) and Google (Android) platforms and is ready for public launch.
A study from Institut Bergoniè (Bordeaux, France), in collaboration with Università Campus Bio-Medico di Roma (Rome, Italy), that set out to compare the duration of targeting and positioning of radiofrequency ablation electrode on lung tumours using two different modalities finds that cone-beam CT is faster than CT.
The study design and initial 30-day safety data of the BEAT Obesity (Bariatric embolization of arteries for the treatment of obesity) study were presented at the SIR annual scientific meeting in Atlanta.
Premedication with an oral antioxidant cocktail before medical imaging exams could significantly reduce deoxyribonucleic acid (DNA) injury from the ionising radiation dose, finds new research presented at the Society of Interventional Radiology’s annual scientific meeting in Atlanta, USA.
Interventional News has learnt that interventional radiologists and urologists in France are teaming up to set up a multidisciplinary registry to collect data on prostatic artery embolization for the treatment of benign prostatic hyperplasia.
Endovascular treatment of intracranial aneurysm is effective in preventing long-term bleeding, but may be followed by aneurysm recurrences in a significant proportion of cases, according to a new magnetic resonance angiography (MRA) study published online in the journal Radiology.
Allium Medical has announced that it has received FDA clearance to market Gardia’s Wirion system in the United States for the carotid indication.
Following the results of SYMPLICITY HTN-3, which failed to show benefit of renal denervation in resistant hypertension patients, Medtronic announced in April the initiation of the SPYRAL HTN clinical trial programme, studying renal denervation in uncontrolled hypertension. Also in April, Boston Scientific announced the initiation of the REDUCE-HTN: REINFORCE, a randomised, sham-controlled study designed to demonstrate the effects of the Vessix renal denervation system by minimising variability and factors that may have affected results in SYMPLICITY HTN-3.
A combination of imaging systems from Siemens Healthcare is helping Southmead Hospital, Bristol, UK, to achieve its aim of becoming a leading provider of health services in Europe. With the hospital’s new £430m Brunel building offering pioneering treatment within state-of-the-art facilities, Siemens technology is increasing the speed of patient assessment and enabling elevated levels of patient throughput.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos